Access to HIV treatment in India by gender 2010-2017

Published by A. Minhas, Jul 12, 2023
This statistic displays the share of access to anti-retroviral drugs in India from 2010 to 2017, sorted by gender. As seen in the graph, 63 percent of females living with HIV in India received access to anti-retroviral therapy compared to 50 percent of males in the same year.

Share of access to anti-retroviral drugs in India from 2010 to 2017, by gender

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2019

Region

India

Survey time period

2010 to 2017

Supplementary notes

Antiretroviral treatment, also known as antiretroviral therapy or ART are the drugs that treat HIV.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Health in Nigeria "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Health in Nigeria

Health services

3

State of health

4

Expenditure

3

Vaccination and prevention

6

Infants' health

3

Diseases

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

HIV/AIDS in BrazilHIV/AIDS worldwideHealth in BrazilPharmaceutical industry in BrazilCoronavirus (COVID-19) in Brazil
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.